Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Home > Addiction Science & Clinical Practice > Volume 4, Number 1

NIDA Addiction Science & Clinical Practice

Volume 4, Number 1 - December 2007

From the Director

Science Versus Stigma
[PDF - 224K]

Nora D. Volkow, M.D.

From the Editor

A New Title and an Invitation
[PDF - 112K]
David Anderson

Research Reviews

Marijuana Dependence and Its Treatment
[PDF - 952K]
Alan J. Budney, Roger Roffman, Robert S. Stephens, and Denise Walker
The prevalence of marijuana abuse and dependence disorders has been increasing among adults and adolescents in the United States. This paper reviews the problems associated with marijuana use, including unique characteristics of marijuana dependence, and the results of laboratory research and treatment trials to date. It also discusses limitations of current knowledge and potential areas for advancing research and clinical intervention.

Assessing Addiction: Concepts and Instruments
[PDF - 896K]
Sharon Samet, Rachel Waxman, Mark Hatzenbuehler, and Deborah S. Hasin
Efficient, organized assessment of substance use disorders is essential for clinical research, treatment planning, and referral to adjunctive services. In this article, we discuss the basic concepts of formalized assessment for substance abuse and addiction, as established by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, and describe six widely used structured assessment instruments. Our aim is to help researchers and clinical programs identify the instruments that best suit their particular situations and purposes.

Clinical Perspectives

Hepatitis C for Addiction Professionals
[PDF - 580K]
Diana Sylvestre

A disease whose reputation is often worse than its reality, hepatitis C is usually benign. Most infected individuals do not experience symptoms requiring treatment, and roughly half of those treated will become free of detectable virus for an extended, perhaps permanent, period. Moreover, a growing body of data suggests that drug users can attain successful treatment outcomes, even when not completely abstinent. Addiction professionals belong in the forefront of prevention and management of this disease. We can assist our patients by helping them stabilize their lifestyles, correcting misperceptions about the disease, teaching prevention and health maintenance, promoting access to diagnosis and treatment, monitoring for treatment side effects, and providing encouragement to remain in treatment.

Managing Addiction as a Chronic Condition
[PDF - 640K]
Michael Dennis and Christy K Scott

This article reviews progress in adapting addiction treatment to respond more fully to the chronic nature of most patients' problems. After reviewing evidence that the natural history of addiction involves recurrent cycles of relapse and recovery, we discuss emerging approaches to recovery management, including techniques for improving the continuity of care, monitoring during periods of abstinence, and early reintervention; recent developments in the field related to self-management, mutual aid, and other recovery supports; and system-level interventions. We also address the importance of adjusting treatment funding and organizational structures to better meet the needs of individuals with a chronic disease.

Authors and Respondents

This Issue's Authors and Respondents
[PDF - 344K]

Graphic Evidence

Cocaine Activates Genes Through Chromatin Remodeling
[PDF - 651K]

Continuing Education Quiz for Counselors

Substance abuse counselors can earn two nationally certified continuing education (CE) hours by reading the indicated articles and completing the multiple-choice quiz. This is an open-book exam. Complete the quiz by circling one or more of the multiple-choice answers. Be sure to answer all questions; unanswered questions will be scored as incorrect. You must score at least 70 percent to earn CE hours. Please note that we must receive your quiz by March 31, 2008.
[PDF - 268K]

- Issue Index
- Subscribe to the Journal
- Information for Authors
- Conflict of Interest Policy
- Journal Staff

Get Adobe Reader

NIDA Addiction Science & Clinical Practice
Subscription Department
MasiMax Resources, Inc.
1375 Piccard Drive, Suite 175
Rockville, MD 20850

Fax: (240) 632–0519



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version

National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, March 11, 2008. The U.S. government's official web portal